PathMate Application icon

PathMate 0.21

31 MB / 1+ Downloads / Rating 5.0 - 1 reviews


See previous versions

PathMate, developed and published by Center for Digital Health Interventions, has released its latest version, 0.21, on 2017-10-26. This app falls under the Health & Fitness category on the Google Play Store and has achieved over 100 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

PathMate APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.pathmate.android

Updated: 7 years ago

Developer Name: Center for Digital Health Interventions

Category: Health & Fitness

Installation Instructions

This article outlines two straightforward methods for installing PathMate on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

PathMate 0.21
2017-10-26 / 31 MB / Android 2.3+

About this app

This PathMate app is currently evaluated in the clinical trial PathMate 2, a program co-funded by the Swiss National Science Foundation (http://p3.snf.ch/project-159289). Usage is restricted to children and adolescents that participate in the PathMate 2 clinical trial. For more information, please contact Dr. Tobias Kowatsch, Center for Digital Health Interventions, ETH Zurich & University of St. Gallen (Switzerland) via tobias.kowatsch@unisg.ch